The objective of the group's current research is to further the molecular study of Inflammatory Bowel Disease (IBD), Ulcerative Colitis and Crohn's Disease, and colon cancer by searching for active anti-inflammatory and anti-tumour agents.
FARMOLAP, Research Group in Molecular and Applied Pharmacology of the University of Seville.